Literature DB >> 4991118

Sub-units of the first complement component in immunologic deficiency syndromes: independence of Cls and Clq.

R M Stroud, K Nagaki, R J Pickering, H Gewurz, R A Good, M D Cooper.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4991118      PMCID: PMC1712843     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  19 in total

Review 1.  Role of the thymus and other central lymphoid tissues in immunological disease.

Authors:  M D Cooper; A E Gabrielsen; R A Good
Journal:  Annu Rev Med       Date:  1967       Impact factor: 13.739

2.  Immunochemical quantitation of the third, fourth and fifth components of human complement: concentrations in the serum of healthy adults.

Authors:  P F Kohler; H J Müller-Eberhard
Journal:  J Immunol       Date:  1967-12       Impact factor: 5.422

3.  Decreased properdin activity in Swiss-type lymphopenic agammaglobulinemia.

Authors:  H Gewurz; R J Pickering; G Naff; R A Good
Journal:  Lancet       Date:  1968-05-04       Impact factor: 79.321

4.  Absence of activity of first component of complement in man: association with thymic alymphoplasia and defective inflammatory response.

Authors:  E J O'Connell; P Enriquez; J W Linman; G J Oleich; F C McDuffie
Journal:  J Lab Clin Med       Date:  1967-11

5.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

6.  Catalysis of C'2 fixation by C'la. Reaction kinetics, competitive inhibition by TAMe, and transferase hypothesis of the enzymatic action of C'la on C'2, one of its natural substrates.

Authors:  R M Stroud; K F Austen; M M Mayer
Journal:  Immunochemistry       Date:  1965-09

7.  Decreased C'-1q protein concentration and agglutinating activity in agammaglobulinaemia syndromes: an inborn error reflected in the complement system.

Authors:  H Gewurz; R J Pickering; C L Christian; R Snyderman; S E Mergenhagen; R A Good
Journal:  Clin Exp Immunol       Date:  1968-06       Impact factor: 4.330

8.  Clinical studies of hemolytic complement and the 11S component.

Authors:  L B Hanauer; C L Christian
Journal:  Am J Med       Date:  1967-06       Impact factor: 4.965

9.  Complement as a mediator of inflammation. II. Biological properties of anaphylatoxin prepared with purified components of human complement.

Authors:  W Dias Da Silva; I H Lepow
Journal:  J Exp Med       Date:  1967-05-01       Impact factor: 14.307

10.  Formation and functional significance of a molecular complex derived from the second and the fourth component of human complement.

Authors:  H J Müller-Eberhard; M J Polley; M A Calcott
Journal:  J Exp Med       Date:  1967-02-01       Impact factor: 14.307

View more
  7 in total

1.  C1r, subunit of the first complement component: purification, properties, and assay based on its linking role.

Authors:  M M De Bracco; R M Stroud
Journal:  J Clin Invest       Date:  1971-04       Impact factor: 14.808

2.  The autosomal recessive mode of inheritance of C1r deficiency in a large Puerto Rican family.

Authors:  M M de Bracco; D Windhorst; R M Stroud; B Moncada
Journal:  Clin Exp Immunol       Date:  1974-02       Impact factor: 4.330

3.  Specific antisera to Clr. Quantitation of Clr in normal and pathological human sera.

Authors:  M M de Bracco; C L Christian; R M Stroud
Journal:  Clin Exp Immunol       Date:  1974-03       Impact factor: 4.330

4.  C1 inhibitor-dependent dissociation of human complement component C1 bound to immune complexes.

Authors:  R B Sim; G J Arlaud; M G Colomb
Journal:  Biochem J       Date:  1979-06-01       Impact factor: 3.857

5.  Antigenic relationship between the C4 inactivating substance produced by KB cell cultures and the first component of human complement (C1).

Authors:  G Füst; S Kósa
Journal:  Med Microbiol Immunol       Date:  1972       Impact factor: 3.402

6.  Metabolism of human C1q. Studies in hypogammaglobulinemia, myeloma, and systemic lupus erythematosus.

Authors:  P F Kohler; H J Müller-Eberhard
Journal:  J Clin Invest       Date:  1972-04       Impact factor: 14.808

7.  EDTA/gelatin zymography method to identify C1s versus activated MMP-9 in plasma and immune complexes of patients with systemic lupus erythematosus.

Authors:  Estefania Ugarte-Berzal; Erik Martens; Lise Boon; Jennifer Vandooren; Daniel Blockmans; Paul Proost; Ghislain Opdenakker
Journal:  J Cell Mol Med       Date:  2018-10-24       Impact factor: 5.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.